Tumor-Associated and Systemic Autoimmunity in Pre-Clinical Breast Cancer among Post-Menopausal Women

Autoantibodies to tumor-associated antigens (anti-TAA) are potential biomarkers for breast cancer, but their relationship systemic autoimmunity as ascertained though antinuclear antibodies (ANA) is unknown and warrants consideration given the common occurrence of autoimmunity and autoimmune diseases...

Descripción completa

Detalles Bibliográficos
Autores principales: Parks, Christine G., Wilson, Lauren E., Capello, Michela, Deane, Kevin D., Hanash, Samir M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669589/
https://www.ncbi.nlm.nih.gov/pubmed/38002248
http://dx.doi.org/10.3390/biom13111566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669589/
https://www.ncbi.nlm.nih.gov/pubmed/38002248
http://dx.doi.org/10.3390/biom13111566

Ejemplares similares